Menu
That’s exactly what we think.
In fact, after much experimentation and trialing, that’s exactly what we now know.
We are a clinical stage medtech company with an innovative, highly effective flush therapy (the Haermonics Laebroides®) that demonstratively prevents post-operative cardiac surgery complications.
Because sometimes the game has to change.
Quite simply, from Dr David Koolbergen’s frustration at complications, unnecessary re-operations and the constant unease of not having any insight in the post-op hemostatic status of his patients. As he stated, “I was really tired of all of this. It wasn’t necessary.” So Koolbergen set about devising a system that would make his life easier…. while saving time, money, worry and – most importantly – the lives of countless patients.
Of course, Dr Koolbergen could not have brought his vision to life without a stellar multidisciplinary team. This team mixes discipline and rigor with creativity and passion (not to mention an extraordinary degree of testing!) to bring a much-needed solution to market.
Their commitment to increasing the quality-of-life and quality-of-care is directly reflected in their quality-as-team.
